Startups channel feed – Endpoints News

Startups channel feed

With an extra $25M in hand, Dauntless maps the next stage of growth for the pipeline

9 years ago

Versant gambles $20 million on a UCSD spinout focused on NASH and fibrosis

9 years ago

Surrozen grabs $33M, joins startups looking to spark a comeback in regenerative med

9 years ago

After winning an early deal on XO1, the virtual biotech gang gets back together for SuperX

9 years ago

Malin backs another microbiome upstart as Artizan breaks out of ‘covert’ role

9 years ago

Celgene vet Daniel takes a startup role at Vividion, with $50M in hand for platform construction

9 years ago

An upstart immunotherapy biotech emerges from stealth mode with big love for Kendall Square

9 years ago

Eli Lilly, Novartis back a $26M round for Cavion’s work on neurological diseases

9 years ago

Ex-Biogen chief George Scangos to spearhead a Gates-backed startup with big plans to fight infectious diseases

9 years ago

An upstart jumps almost overnight from preclinical to PhI with a $35M Takeda deal and a buyout option

9 years ago

Another Langer-backed biotech breaks out of stealth mode, aims for the clinic with hearing loss therapy

9 years ago

Neon Therapeutics bags a $70M round for early-stage neoantigen research

9 years ago

Medigene spins out AAV tech to a new biotech upstart in Sweden

9 years ago

Shanghai biotech upstart raises $50M, bags antibody discovery group and ramps up Boston unit

9 years ago

Armed with $55M in Third Rock cash, Goldfinch Bio sets out to build a kidney disease pipeline

9 years ago

Pfizer bankrolls an oncolytics biotech upstart with an eye on a future buyout

9 years ago

Thinking big, Bayer’s Axel Bouchon tackles stem cell field with $225M startup partnered with Versant

9 years ago

MPM kicks off a new I/O player with $44.5M round and a new understanding of the T cell receptor

9 years ago

Sayonara Novartis: Ex-cell therapy chief challenges CAR-T leaders, moves to Carl June’s biotech startup

9 years ago

Gladstone spinout Tenaya tackles new cures for heart failure with $50M A round

9 years ago

Cutting back in the UK, Takeda spins out its top neuroscience team into a transatlantic biotech

9 years ago

Goodbye, San Francisco. Stanford spinout heads to Houston after bagging a $20M CPRIT grant

9 years ago

GSK vet Jason Gardner takes the helm of Magenta, emerging from stealth with a $48.5M round

9 years ago

NYC’s top research institutions partner on Step 2 in building a biotech hub

9 years ago

First page Previous page 70 71 727374 Next page Last page